[{"address1": "Rue Edouard Belin 12", "city": "Mont-Saint-Guibert", "zip": "1435", "country": "Belgium", "phone": "32 10 22 23 55", "website": "https://www.nyxoah.com", "industry": "Medical Instruments & Supplies", "industryKey": "medical-instruments-supplies", "industryDisp": "Medical Instruments & Supplies", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.", "fullTimeEmployees": 137, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert  Taub MBA", "age": 76, "title": "Co-Founder & Chairman", "yearBorn": 1947, "fiscalYear": 2022, "totalPay": 83521, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Olivier  Taelman", "age": 51, "title": "CEO & Executive Director", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": 683793, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Loic  Moreau", "age": 43, "title": "Chief Financial Officer", "yearBorn": 1980, "fiscalYear": 2022, "totalPay": 343464, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bruno  Onkelinx", "title": "Chief Technology Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mikaela  Kirkwood", "title": "Corporate Communication & Investor Relations Manager", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. An  Moonen", "title": "General Counsel", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Remi  Renard", "title": "Vice President of Market & Market Access", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Inge  Vanwittenbergh", "title": "Global Human Resource Director", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David M. DeMartino", "title": "Chief Strategy Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeyakumar  Subbaroyan", "title": "Chief Clinical Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 8.14, "open": 8.99, "dayLow": 8.5601, "dayHigh": 9.7, "regularMarketPreviousClose": 8.14, "regularMarketOpen": 8.99, "regularMarketDayLow": 8.5601, "regularMarketDayHigh": 9.7, "beta": 0.449, "forwardPE": -5.9720497, "volume": 131192, "regularMarketVolume": 131192, "averageVolume": 33031, "averageVolume10days": 82320, "averageDailyVolume10Day": 82320, "bid": 9.5, "ask": 9.72, "bidSize": 1100, "askSize": 1100, "marketCap": 407623104, "fiftyTwoWeekLow": 4.0, "fiftyTwoWeekHigh": 12.613, "priceToSalesTrailing12Months": 106.40123, "fiftyDayAverage": 5.15526, "twoHundredDayAverage": 6.976105, "currency": "USD", "enterpriseValue": 173871232, "floatShares": 11839488, "sharesOutstanding": 28674000, "sharesShort": 167704, "sharesShortPriorMonth": 105176, "sharesShortPreviousMonthDate": 1702598400, "dateShortInterest": 1705017600, "sharesPercentSharesOut": 0.0058, "heldPercentInsiders": 0.45630002, "heldPercentInstitutions": 0.27154, "shortRatio": 5.1, "shortPercentOfFloat": 0.0095999995, "impliedSharesOutstanding": 42394500, "bookValue": 3.785, "priceToBook": 2.5402906, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -45615000, "trailingEps": -1.82, "forwardEps": -1.61, "enterpriseToRevenue": 45.385, "enterpriseToEbitda": -4.053, "52WeekChange": 0.521211, "SandP52WeekChange": 0.19561028, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "NYXH", "underlyingSymbol": "NYXH", "shortName": "Nyxoah SA", "longName": "Nyxoah S.A.", "firstTradeDateEpochUtc": 1619616600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "067cdc20-d2e6-3884-af4a-437fe8703370", "messageBoardId": "finmb_264235912", "gmtOffSetMilliseconds": -18000000, "currentPrice": 9.615, "targetHighPrice": 14.93, "targetLowPrice": 9.96, "targetMeanPrice": 11.35, "targetMedianPrice": 9.96, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 72489000, "totalCashPerShare": 2.528, "ebitda": -42898000, "totalDebt": 12954000, "quickRatio": 5.314, "currentRatio": 5.55, "totalRevenue": 3831000, "debtToEquity": 11.935, "revenuePerShare": 0.141, "returnOnAssets": -0.18128, "returnOnEquity": -0.37759, "freeCashflow": -43262124, "operatingCashflow": -43468000, "revenueGrowth": 4.363, "grossMargins": 0.63587004, "operatingMargins": -11.25615, "financialCurrency": "EUR", "trailingPegRatio": null}]